Medlab in 2024
The four-day 2024 Arab (Dubai) International Medical Laboratory Instrument and Equipment Exhibition ended successfully on February 8th! Xiamen Wizbiotech Co., Ltd. had presented WIZ-A101, the portable immunoassay analyzer, the five-in-one combined test reagents card (DiabenchTM) for infectious diseases, the HPV test reagent, etc., to the show, made the WIZ’s booth particularly eye-catching and crowded with visitor follows.
Surprising in the show!
Wizbiotech's portable immunoassay analyzer WIZ-A101 was unveiled at the exhibition site. It is mini but precise, fast, intelligent,which left a deep impression to the customers from all over the world.
WIZ-A101 has been certified by CE(IVDR), covering twenty more oversea markets, solving the problems of lack of space and manpower in the small to medium-sized hospitals and primary medical institutions. WIZ-A101 supports more than 100 detection items like digestive tract, respiratory tract, chronic diseases, tumor markers, infectious diseases and drug detection, it is also convenient for the big hospitals when they want to add more check items.
WIZBIOTECH's five-in-one test reagent card (DiabenchTM) for infectious disease detection also got high praise by the visitors. Just with one drop of blood, DiabenchTM can detect blood type and four kinds of infectious diseases, including hepatitis B, hepatitis C, AIDS and syphilis at the same time. It is helpful to access the individual's disease risk, ensure blood transfusion safety and take corresponding preventive measures.
HPV detection has always been a hot topic in the field of women's health. The incidence of cervical cancer keeps increasing and the patients tend to be younger and younger. Therefore screening and preventing cervical cancer becomes more and more important. The World Health Organization points out that the cervical cancer can be cured if it diagnosed and treated in early stage, and recommends human papillomavirus (HPV) nucleic acid detection as the first choice for the cervical cancer screening.
Wizbiotech's high-risk human papillomavirus nucleic acid detection kit (fluorescence PCR method) can meet the screening needs of HPV infected persons and the shunt management needs for high-risk people, accurately guide the clinical diagnosis and treatment.
Grateful to all kind support all the way
Medlab Dubai 2024 exhibition had come to a successful conclusion, and we appreciate all kind support so far. In the future, wizbiotech will continue to adhere to the motto of "focusing on diagnostic technology and improving the quality of life", and constantly launch high quality and advanced medical equipment and test reagent products, provide better service to our customers, and work together for a better future.
